Additionally, in our series, the most common KRAS alterations were p.G12C (32%), p.G12V (28%), and p.G12D (17%), and other p.G12/G13 mutations (23%) were similar to that previously reported both in surgically resected early-stage NSCLC and the advanced ones [24,32]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.